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Abstract
The biological effects of interventions to control infectious diseases typically depend on the intensity of pathogen
challenge. As much as the levels of natural pathogen circulation vary over time and geographical location, the development
of invariant efficacy measures is of major importance, even if only indirectly inferrable. Here a method is introduced to
assess host susceptibility to pathogens, and applied to a detailed dataset generated by challenging groups of insect hosts
(Drosophila melanogaster) with a range of pathogen (Drosophila C Virus) doses and recording survival over time. The
experiment was replicated for flies carrying the Wolbachia symbiont, which is known to reduce host susceptibility to viral
infections. The entire dataset is fitted by a novel quantitative framework that significantly extends classical methods for
microbial risk assessment and provides accurate distributions of symbiont-induced protection. More generally, our data-
driven modeling procedure provides novel insights for study design and analyses to assess interventions.
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Introduction
Hosts exposed to disease-causing agents respond in accordance
to the challenge dose. Therefore dose-response curves contain
information about disease processes that can be extracted by
suitable analytic frameworks. Early examples concerning micro-
bial risk assessment include counting lesions caused by tobacco
mosaic virus on plant leaves [1], as well as human responders to
experimental challenge with polio viruses [2], Vibrio cholerae [3]
and Streptococcus pneumoniae [4], for escalating challenge doses.
Dose-response models have been in use for analyses and
extrapolation of experimental datasets [5].
Models that account for the sigmoidal shape in log-linear scale
of the typical dose-response curve have been derived mechanis-
tically, based on the assumption that each individual pathogen has
a probability of infection independent of others, the so-called
independent action hypothesis [6]. This results in a one-parameter
exponential-function model [7]. The frequent observation of
shallower-than-exponential, or overdispersed, relationships has
then prompted the implementation of heterogeneity in the
probability of infection of individual hosts [8–10].
In the 1960s, Furumoto andMickey [9] developed a dose-response
model that could accommodate both shallow and steep increases in
the response by considering the probability of infection of individual
hosts described by a Beta-distribution. Although a mechanistic
justification for this specific distribution has not been given, the model
has been widely applied in microbial risk assessment due to its ability
to outperform the simple exponential model [5].
Susceptibility distributions other than Beta have also been
considered and are more commonly used in frailty models adopted
in survival analysis [11], where the data consist of survivor counts
over time in host groups that are constantly subject to a hazard
[12,13]. These frailty models appeared in the 1980s and have since
been adapted to infection hazards, where surviving signifies
remaining uninfected [14–16]. While most informative when the
exposure is continued or repeated over time, these formalisms
would be inadequate for estimating distributions of susceptibility to
infection from instantaneous challenge protocols.
The importance of accounting for time between challenge and
observable toxicity responses to pathogens or other agents has
been recognized. Recent models in ecotoxicology [17,18],
consider explicit kinetics within exposed organisms. Also in
microbial risk analysis, previous studies [19,20] have included
time postinoculation as an additional parameter in classic dose-
response models, although using an approach that conceptually
allows for a different susceptibility distribution at each time point.
Here we present a schema to infer a distribution of host
susceptibilities to infection that holds consistently across dose
and time. We introduce an experimental design and inference
framework that enables such inferences by analyzing simulta-
neously a collection of survival curves, each representing a
different challenge dose. The resulting Beta distributions are
compared against those obtained by classic dose-response models
based on single day measurements.
Recent evidence for symbiotic interactions that reduce host
susceptibility to pathogens has stimulated the development of
quantitative frameworks to assess the levels of individual and
population protection attributable to specific symbionts. The
intracellular bacterium Wolbachia, found among many arthropod
species including Drosophila melanogaster, is one such symbiont
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[21,22]. To analyze the protection conferred by Wolbachia to D.
melanogaster, we apply our inference framework simultaneously to
two sets of time-dependent dose-response data: in one set the flies
carry the symbiont bacterium Wolbachia (Wolb+); while in the
other they do not (Wolb2). In this instance we extract the Beta
distribution that best describes individual protection attributable to
Wolbachia, as well as population statistics valid across entire dose
ranges.
Methods
Survival data
We used virus free D. melanogaster lines with DrosDel w1118
background, with or without the endogenous Wolbachia strain
wMelCS [21,23,24]. Flies were reared in standard food at 25uC.
To assure that potential for heterogeneities are minimized by the
experimental procedure, we used fifty 3–6 days old adult males per
group, 10 per replicate and 5 replicates. To study the response to
viral infection, we anesthetized with CO2 and pricked flies with
different doses of Drosophila C virus (DCV). We used tenfold serial
dilutions – from 1010 TCID50/ml to 10
4 TCID50/ml – in Tris-
HCl buffer, pH 7.5. Controls were pricked with buffer solution
only. We used the pricking protocol described in [24], produced
and titrated virus as in [21]. After pricking, we kept flies at 18uC
and checked daily survival until day 80 and twice a week until the
end of the experiment. Food was changed every 5 days. We
summarized the data in 16 dose-response curves (8 per group,
including control) from day 0 after treatment until day 139
(Dataset S1).
Dose-response model
Starting from established models, we refine the occurrence of
mortality from infection, i.e. the response, as a function of the
concentration of infectious units given to hosts, i.e. the dose. We
present a step-by-step derivation of descriptions that integrate
dimensions that are usually treated separately as well as the
motivations for doing so.
Assuming independent action of infectious units, each unit
has probability p of causing an infection, while for d infectious
units infection occurs with a probability described by
Binomial(d, p). Given further considerations about the distri-
bution of infectious units in a homogeneous solution (see [9] for
a complete derivation of the expression), the number of units
causing infection can be described by a Poisson distribution,
resulting in the exponential dose-response model [7], that
describes the probability of infection in a host challenged with
pathogen dose d:
phom~1{e
{pd : ð1Þ
This most basic formulation is hereafter referred to as the
homogeneous dose-response model.
Furumoto and Mickey [9] expanded this formulation by
allowing the probability of infection to be described by a
parametric distribution, specifically the Beta distribution. To
facilitate normalization across datasets, here we maintain the
probability p fixed across individual hosts (as in [25]), and
introduce a multiplicative parameter, the susceptibility factor
0vxv1, to describe any natural or induced effect that decreases
susceptibility. We assume that susceptibility to infection is Beta-
distributed so as to describe the variation of susceptibility in the
host population. Thus, we obtain the probability phet that a host
contracts infection as
phet~1{
ð1
0
e{xpdq(x) dx, ð2Þ
where q(x)~xa{1 1{xð Þb{1
.
B(a,b) andB is the Beta function.We
refer to this formulation as the heterogeneous dose-response model.
At last we introduce a small parameter e to account for a small
probability of ineffective challenge, such that M*Binomial n,ð
1{eð ÞpÞ is the random variable representing the number of
infected hosts, in a group of n hosts challenged with a given dose.
Assuming that an ineffectively challenged host behaves like a control
host with regard to death rates, the probability thatm hosts are dead
a number of days after challenge is then
P(M~m)~
n
m
 
1{eð Þp½ m 1{ 1{eð Þp½ n{m, ð3Þ
where p is either phom (1) or phet (2) depending on which dose-
response model is adopted.
The parameters to be estimated for this dose-response model
are the maximum probability of infection per infectious unit (p),
the shape parameters for the Beta distribution that describes the
susceptibility factor (a, b), and the probability of ineffective
challenge (e ).
These models require a choice of how many days post-challenge
cumulative mortality should be measured, which is difficult to
establish for host-pathogen systems where times to death from
infection or other causes overlap significantly. To overcome this
difficulty, we develop a model that integrates an explicit
representation of time to death with the dose-response process
for infection just described. It should, however, be noted that time
is introduced with the main purpose of enabling the use of survival
curves to obtain robust estimates for probabilities of infection given
different challenge intensities and consistently infer susceptibility to
infection. From this perspective, parameters defined from now on
should be regarded as auxiliary and will be implemented as simply
as possible.
Author Summary
While control options for plant, animal, and human
pathogens are emerging rapidly, reliable assessment of
the effect of interventions in biological systems presents
many challenges. A major question is how to connect
laboratory experiments and measurements with the
relevant process in natural settings, where hosts are
subject to pathogen exposures that vary in time and
geographical location. With this aim, measures of protec-
tion that are invariant under varying exposure intensity
need to be developed and integrated with mathematical
models. In this article, we introduce a method to assess
host susceptibility to pathogens, and apply it to survival of
Drosophila melanogaster challenged with different doses
of Drosophila C virus. By replicating the procedure in
groups of flies that carry the symbiont Wolbachia, we are
able to estimate how the viral protection induced by this
intracellular bacterium is distributed in the host popula-
tion. Our results disentangle host infection status from
observed mortality, accounting naturally for time since
exposure. The multiple-dose design proposed challenges
traditional study designs to assess interventions.
Unveiling Time in Dose-Response Models
PLOS Computational Biology | www.ploscompbiol.org 2 August 2014 | Volume 10 | Issue 8 | e1003773
Time-dependent model for control group
We first consider a survival model for a control group of flies
pricked with buffer solution only (no DCV), subject to two
hazards: h0, an age-dependent death hazard rate; and hk, a
background age-independent death hazard rate. The overall death
hazard rate for uninfected hosts is therefore
hU (t)~h0(t)zhk(t): ð4Þ
Denoting TU the random variable representing time to death of
control hosts, we have
P TU~tð Þ~P Tk~tð ÞP T0wtð ÞzP T0~tð ÞP Tkwtð Þ, ð5Þ
where T0 and Tk are the times to death from h0 and hk,
respectively. Their corresponding distributions are assumed to be
T0*Gamma m0, s0ð Þ and Tk*Uniform(1=k) , where k is the
background mortality rate, m0 is the mean time to death, and s0 is
the shape parameter for the Gamma distribution of day of death
from aging.
Time-dependent dose-response model
Hosts challenged with pathogen can become infected or remain
uninfected and this infection status is hidden. If uninfected, they
are subject to the age-dependent hazard rate that affects control
hosts, hU ; if infected, they are subject to an infection hazard rate,
h1, and the age-independent background mortality. Thus the
overall hazard rate of infected hosts is
hI (t)~h1(t)zhk(t): ð6Þ
Now let I * Binomial n, 1{eð Þpð Þ be the random variable
representing the number of hosts infected by challenge with a
given pathogen dose. Then the probability that i hosts are infected
after n hosts were challenged is
P I~ið Þ~ n
i
 
1{eð Þp½ i 1{ 1{eð Þp½ n{i, ð7Þ
where p is either phom (1) or phet (2) depending on which dose-
response model is adopted.
Let T be the random variable representing the time to death of
hosts challenged by a given pathogen dose. The probability density
of observing a death event at time t given that i hosts are infected is
P T~tjI~ið Þ~ (n{i)
n
P TU~tð Þz i
n
P TI~tð Þ, ð8Þ
where TI denotes the distribution of time to death of infected
hosts, given by
P TI~tð Þ~P Tk~tð ÞP T1wtð ÞzP T1~tð ÞP Tkwtð Þ ð9Þ
and T1 is the distribution of times to death from the infection
hazard rate h1. This distribution is assumed to follow
T1 * Gamma m1, s1ð Þ, where m1 is the mean time to death of
infected hosts, and s1 is the shape parameter for the Gamma
distribution of day of death from infection.
In setting the priors for parameter estimation we note that
background mortality is small and therefore k is kept small by
setting 1=k to be much greater than the last day of the
experiment. To enforce that deaths due to infection occur earlier
than deaths due to aging, we constrain the mean time to infection
death to be lower than old-age death, i.e. m1vm0, and the
probability of dying before the end of the study to be greater for
infected hosts, i.e. P T0ƒtmaxð ÞƒP T1ƒtmaxð Þ, where tmax is the
last day of the experiment.
To construct the likelihood to be maximized by the parameter
estimation procedure, we let Dj be the random variable denoting
the day fly j died and S the random number of survivors up to
tmax. Then the likelihood of observing the actual number of
survivors s and the times of death d~ d1, . . . , dn { s½ , for a
given dose is
P(S~s, D~d) ~
Xn
i~1
P(S~s,D~djI~i)P(I~i)
~
Xn
i~1
P(TwtmaxjI~i)sP
n{s
j~1
P(dj{1vTvdj jI~i)
2
4
3
5P(I~i)
ð10Þ
Since the observations for each dose are independent, taking the
product of the likelihoods over the different doses yields the global
expression for the likelihood of the entire dataset.
In this time-dependent dose-response model, the parameters to
be estimated are the maximum probability of infection per
infectious unit (p) used for normalization purposes, the Beta
distribution shape parameters to describe variation in susceptibility
factor (a,b), the parameters that control death due to aging (m0, s0),
infection (m1, s1), and background mortality (k ), as well as
probability of ineffective challenge (e ). Parameters k and e are
typically small and were introduced to improve performance of the
likelihood.
Parameter estimation
Model parameters were estimated using Markov chain Monte
Carlo sampling implemented with the PyMC package [26] (code
available from [27]). The prior distributions considered are
listed in Table 1. Initial values were chosen so as to start with a
non-zero likelihood. Using Metropolis-Hastings algorithm, we
ran two separate chains for 252,000 iterations. The first 27,000
iterations were discarded. The recording interval was set to 250
so that the autocorrelation between samples was negligible.
Convergence was assessed by inspection of the trace plots. All
analyses were performed on the pooled samples from the two
replicate chains.
Results
Groups of Wolbachia-negative (Wolb2) and positive (Wolb+) D.
melanogaster flies were challenged with a range of DCV doses and
survival curves were traced as shown in Figure 1. This dataset was
analyzed by applying the models introduced in Methods.
Susceptibility distribution from selected day mortality
To emphasize the importance of day selection to infer
distributions of susceptibility to infection by classic dose-response
models [5] we have applied these procedures to mortality data
observed by two specific days (30 and 50). Parameter estimates
from these models are listed in Table 2. The model fits to the
mortality data at the selected days are shown in Figure 2, as well as
the associated distribution of Wolb+ susceptibilities and the
posterior samples for the Beta distribution shape parameters. For
simplicity we have adopted the homogeneous model for Wolb2
and focus on comparing susceptibility distributions of Wolb+
inferred at different days. Mean protection conferred by
Unveiling Time in Dose-Response Models
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Wolbachia in this illustration is estimated as 79% and 56%, based
on mortality measurements at day 30 and 50, respectively.
Moreover, the distributions have fundamentally different shapes,
with the appearance of a high susceptibility group as time
progresses. This sensitivity to the day by which mortality data are
collected is a concern that raises the need to disentangle infection
status from the associated time-dependent mortality. In the
following sections, infection and mortality are estimated explicitly
using the integrated time-dependent model described in Methods.
The procedure is illustrated in Figure 3.
Aging and background mortality
Control curves from Wolb2 and Wolb+ flies pricked with buffer
solution (no DCV) were compared with the Kaplan-Meier method
using the log-rank test and no significant difference was found
(with a p-value of 0.47). By fitting the uninfected time-dependent
model (4–6) to the control survival curves (Figure 1) we estimated
the parameters describing aging (m0, s0) and background (k)
mortality (Table 3).
Susceptibility distribution from survival curves
For each group of flies (Wolb2 and Wolb+), the time-dependent
dose-response model constructed in Methods was fitted simulta-
neously to the entire dataset of survival curves (one for each DCV
challenge dose), fixing across doses the distribution of times to death
from infection (mI , sI ) and aging (m0, s0), while estimating the
susceptibility parameters (p, a, b) that govern the dependence of
response on challenge dose according to the adopted dose-response
model. The estimated parameter values are listed in Table 4. The
deviance information criterion (DIC) [28] favored the homogeneous
model for the Wolb2 group and the heterogeneous model for Wolb+
(Text S1). Mean time to death from infection is 9 and 14 days in the
Wolb2 and Wolb+ groups, respectively. The variance in time to
death from infection is lower for Wolb2, with a standard deviation of
2 days, compared to 6 days in the Wolb+. Figure 4 compares fitted
with observed survival curves.
The fitted dose-response curves that result from this analysis are
shown in Figure 5A, while the inferred distribution of Wolb+
susceptibilities normalized by the Wolb2 measure is displayed in
Figure 5B and the corresponding posterior distribution of the Beta
shape parameters is in Figure 5C. Given the homogeneity in the
Wolb2 group, the distribution of susceptibility in Wolb+ provides a
direct indication of how antiviral protection conferred by
Wolbachia is distributed among its carriers. Typically defined as
1 { RR, where RR is the risk reduction attributed to the
susceptibility modifier (Wolbachia in this case), we determine the
mean protection conferred by the symbiont to its host as 85%
(with a 95% HPD of 60–93%).
Comparison with selected day mortality
To assess the best possible performance of classic methods [5] in
the inference of susceptibility distributions (for Wolb+ in the case)
Table 1. Model parameters and their corresponding prior distributions.
Symbol Meaning Prior
m0 Mean time to death from aging U 0, 140ð Þ
s0 Shape of the Gamma distribution for death from aging U 0, 500ð Þ
m{1 , m
z
1
Mean time to death from infection (for Wolb2 and Wolb+, respectively) U 0,m0ð Þ
s{1 , s
z
1
Shape of the Gamma distribution for death from infection (for Wolb2 and Wolb+) U 0, 100ð Þ
p Per viral particle probability of causing infection U 0, 1ð Þ
a, b Shape parameters of the Beta distribution for the susceptibility to infection of Wolb+ U 0:1, 10ð Þ
k Background mortality rate, from causes other infection or aging U 10{6, 10{2
 
e Probability of ineffective challenge N 0:001, 0:00125ð Þ 0,1½ 
U(x,y) is a Uniform distribution from x to y. N(x,y)[w,z] is a normal distribution with mean x and standard deviation y truncated so its values are always between w and z.
doi:10.1371/journal.pcbi.1003773.t001
Figure 1. Survival curves for Wolb2 (A) and Wolb+ (B) groups of D. melanogaster. Dots represent experimental data. Dark blue curves show
the model fit to the survival of control flies. Shaded areas represents 95% CI (credible intervals).
doi:10.1371/journal.pcbi.1003773.g001
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we must have previously reduced the set of survival curves to a set
of effectively infected proportions - one entry per challenge dose.
To search for a range of days in which absolute mortality might
provide an approximate indication of infection, we compare the
estimated proportions effectively infected by each challenge dose
with the mortality proportion measured at each day. Using a
normalized Euclidean distance between these two measures, a
day-selection score is provided by the red curve in Figure 6. We
identify day 30 as optimal and 17–46 as the interval of days in
which the score is at least 95% of the optimal. Reassuringly, the
optimal day appears to coincide with the saturation of infection-
induced mortality (see position of vertical dash-dotted gray line in
relation to the Gamma distributions). We now recall Figure 2 and
Table 2 for the inferences based on day 30 mortality data to
confirm that classic dose-response models can in principle infer
susceptibility distributions that are consistent with those obtained
Table 2. Estimated parameters by applying dose-response models to selected day mortality.
Mortality data Parameter Median 95% HPDa
30 dpcb p 2.33 1026 [1.67 1026, 3.13 1026]
a 0.30 [0.21, 0.41]
b 1.10 [0.29, 2.53]
e 1.78 1023 [4.90 1024, 3.49 1023]
50 dpcb p 2.65 1026 [1.82 1026, 3.47 1026]
a 0.34 [0.24, 0.51]
b 0.42 [0.12, 0.93]
e 1.83 1023 [3.60 1024, 3.32 1023]
aHigh posterior density interval.
bDays post-challenge.
doi:10.1371/journal.pcbi.1003773.t002
Figure 2. Dose-response curves and susceptibility distributions inferred from mortality measurements 30 and 50 days post-
challenge. Dose-responses models adopted here are the standard formulations (1–3). A,D, Curves represent the fitted dose-response model to
mortality on selected day post-challenge (dots), for Wolb2 (black) and Wolb+ (blue). Shaded areas represent the 95% CI. B,E, Distribution of
susceptibility to infection in Wolb+. The posterior median distribution is the curve and the shaded area is the 95% CI. C,F, Posterior samples of the
Beta-distribution shape parameters describing Wolb+ susceptibility in blue. Red dot mark the median of the respective distributions. The
homogeneous model was adopted for Wolb2.
doi:10.1371/journal.pcbi.1003773.g002
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under our extended model (Figure 5). A major issue, however, is
that results are sensitive to a day-selection criterion that relies on
having previously carried out the entire procedure. The appearance
of a high susceptibility group in distributions inferred at later days
are an artifact due to the accumulation of backgroundmortality that
should be factored out. These results highlight the importance of
adequately representing the time dimension in the analysis.
Discussion
Dose-response models have become standard quantitative
frameworks in microbial risk assessment. Less recognized is their
ability to estimate host trait distributions. Here we illustrate the
concept by extracting host susceptibility distributions from
mortality measured as a function of pathogen challenge dose,
but similar procedures can be developed for measures of infection
or infectiousness (instead of mortality), and can be made a function
of other environmental variables such as temperature or humidity
(instead of dose). Understanding how to detach host trait
distributions from environmental variables is crucial for the
Figure 3. Schematic illustration of the proposed experimental design and inference procedure.
doi:10.1371/journal.pcbi.1003773.g003
Table 3. Estimated parameters governing time to death from
causes other than DCV infection.
Parameter Median 95% HPD
m0 117.18 [114.99, 119.84]
s0 118.93 [80.19, 166.15]
k 1.14 1023 [5.36 1024, 1.96 1023]
doi:10.1371/journal.pcbi.1003773.t003
Table 4. Parameters governing estimated number infected per
dose of DCV challenge and time to death from infection using
time-dependent dose-response models described in Methods.
Parameter Median 95% HPD
p 1.73 1026 [9.58 1027, 2.67 1026]
a 0.47 [0.25, 0.85]
b 3.21 [0.34, 8.40]
e 1.89 1023 [4.55 1024, 3.40 1023]
m{1 9.34 [9.10, 9.58]
s{1 35.79 [26.60, 47.05]
mz1 13.79 [11.31, 14.94]
sz1 5.59 [4.70, 11.12]
m0 115.20 [113.94, 116.45]
s0 140.39 [116.80, 166.97]
k 2.15 1023 [1.65 1023, 2.71 1023]
Parameters with superscripts 2 and + relate to Wolb2 and Wolb+ groups,
respectively.
doi:10.1371/journal.pcbi.1003773.t004
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formulation of measures that can be transported between
laboratory and natural conditions [29,30].
We address this problem with an experimental design and
inference framework that enables the estimation of distributions of
host susceptibility to infection by analyzing simultaneously a
collection of survival curves, each representing a different
challenge dose (Figure 3). The procedure is illustrated on a
specifically collected dataset where two distinct groups of hosts (D.
melanogaster) were experimentally challenged by viruses (DCV):
one group consists of isogenic flies where no significant variability
in susceptibility to infection is found; and another with the same
genetic background but now carrying the symbiont bacterium
Wolbachia known to reduce susceptibility to DCV [21,22].
Our inferences indicate that Wolbachia confers on average 85%
DCV protection to D. melanogaster under the specified laboratory
conditions, and suggest significant variability in this effect. This
variance in susceptibility is induced by the symbiont, since model
selection criteria did not support heterogeneity in the susceptibility
of flies not carrying Wolbachia. Since the Drosophila and
Wolbachia populations used in this study are isogenic, the
heterogeneity in susceptibility of Wolbachia-carrying flies uncov-
ered here indicates variation in the host-microorganism interac-
tion that lacks a genetic basis. A simple hypothesis is that variance
in Wolbachia levels at the individual host level leads to variance in
resistance to viruses. Although several lines of evidence support
this hypothesis [31–34], further experiments are required to
discriminate whether heterogeneity in resistance is directly linked
to variance inWolbachia levels or, alternatively, a result of another
environmental/physiological variance that is only expressed in the
presence of Wolbachia.
Previous estimates of protection were based on survival analysis
or viral titres in a dose-specific manner [21,22,24]. To our
Figure 4. Fit of time-dependent dose-response model to survival curves. Black and blue dots are the observed proportions surviving over
time for Wolb2 and Wolb+ groups, respectively. The curve is the fitted mean posterior survival over time and the shaded area is the 95% CI. Fifty flies
per group were pricked with: A, buffer solution (shown for comparison but not used on this analysis); and B, 104 ; C, 105 ; D, 106 ; E, 107 ; F, 108; G, 109 ;
H, 1010 TCID50 DCV.
doi:10.1371/journal.pcbi.1003773.g004
Figure 5. Dose-response curves and susceptibility distributions inferred from survival curves. A, Curves represent the estimated dose-
response relationships from fitting the model described in Methods to survival over time, for Wolb2 (black) and Wolb+ (blue). Shaded areas represent
the 95% CI. B, Distribution of susceptibility to infection in Wolb+. The posterior median distribution is the curve and the shaded area is the 95% CI. C,
Posterior samples of the Beta-distribution shape parameters describing Wolb+ susceptibility in blue. Red dot marks the median of distribution.
doi:10.1371/journal.pcbi.1003773.g005
Unveiling Time in Dose-Response Models
PLOS Computational Biology | www.ploscompbiol.org 7 August 2014 | Volume 10 | Issue 8 | e1003773
knowledge, the experimental design and analysis presented here
provides the first estimation of protection in way that is detached
from challenge dose. Future developments might consider:
estimation of alternative distributions to compare with the shapes
suggested by the Beta family; extension of the adopted experi-
mental design to measure responses other that mortality; and
move towards host populations and environmental conditions that
are closer to natural systems.
The parameters estimated here should not be seen as isolated
from the relevant ecological context. On the contrary, they are
intended as a first step to inform the construction of ecological and
epidemiological models where Wolbachia, other symbionts, or
interventions that modify host susceptibility to infection, are
introduced to induce desired transitions in populations. The
introduction of Wolbachia into Aedes aegypti and other arthropod
vectors is being considered as a promising strategy to control
dengue and other infectious diseases of humans (see [35] and
references therein). The inference frameworks presented can be
readily adapted to provide accurate quantification of Wolbachia-
induced protection and integrated in population models of public
health importance.
The challenge of considering the time dependence of processes
leading to observable ecotoxicity responses has also been
addressed in toxicology where the so-called General Unified
Model of Survival (GUTS) has been proposed [18]. These models
simulate the time-course of external and internal processes leading
to toxic effects on organisms to generate an output that can be
fitted to mortality over time. While those studies tend prioritize the
mechanistic descriptions of the toxicokinetic and toxicodynamic
processes that damage the organisms, we have chosen to adopt a
phenomenological approach and focus on the inference and
interpretation of how susceptibility to infection is distributed in a
population.
In epidemiological systems, the baseline transmission intensity is
often not directly measurable but indirectly inferred in a model-
based manner. Dose-response models, on the other hand, can
account for experimentally controlled patterns of exposure
[36,37]. Variation in host susceptibility to pathogens is one
component of both classes of systems that mostly influences
estimates of intervention impacts [29]. Therefore, building on the
methods developed here furthers our potential to accurately
evaluate the burden of infectious diseases and design effective
interventions.
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